Impact of Vitamin B12, Folate and Homocysteine in Modulating Cognitive Functions and the Brain’s White Matter Hyperintensity in Alzheimer’s Disease
Annals of Neurosciences · 15.07.2026
DOI: 10.1177/09727531261457693 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Neurosciences, online erschienen am 15.07.2026. Verfasst von Ram Prakash Sah und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, Shridevi Institute of Medical Sciences & Research Hospital, Tumkur, Karnataka, India. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Demenz
Abstract (Originalsprache)
Background
Deficiency of vitamin B12 and folate as surrogate factors attributed to cognitive deterioration among older adults with Alzheimer’s disease (AD). Increased homocysteine levels >15 µmol/L (hyperhomocysteinaemia) due to insufficiency of vitamin B12 contribute to damage to the small blood vessels in the brain and aggravate the white matter lesion.
Purpose
The study aimed to determine the impact of B12, folic acid and homocysteine in modulating cognitive functions and white matter hyperintensity in AD.
Methods
A case-control study of a total number of 82 patients (41 AD patients and 41 controls) was recruited. The cognitive functions were assessed by the Montreal Cognitive Assessment (MoCA), and white matter hyperintensity was marked by magnetic resonance imaging studies. The levels of vitamin B12, folic acid and homocysteine in serum were also assessed.
Results
The noticeable changes were observed in the cognitive scores and levels of B12, folic acid and homocysteine in AD and controls and found statistically significant ( p < .001). Spearman’s rank correlations revealed that cognitive functions (MoCA score) showed a direct correlation with B12 ( ρ = 0.513, p < .001). Conversely, MoCA was moderately negatively correlated with homocysteine ( ρ = −0.422, p < .001). Participants with B12 deficiency showed a significantly higher frequency of white-matter hyperintensities (WMH) ( χ ² = 4.654, p = .031; Fisher’s exact p = .048).
Conclusion
Nutrient deficiencies, especially B12, have a disruptive impact on cognitive domains and WMH in AD, which could be considered as key indicators to identify the disease severity among older adults. Recommendations of vitamin B12 plus supplements might be connected to clinical and public health initiatives to halt the rate of progression of cognitive decline in AD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anatomy, Shridevi Institute of Medical Sciences & Research Hospital, Tumkur, Karnataka, India.
- Department of Anatomy, JSS Medical College Mysore, Karnataka, India.
- Department of Biochemistry, Mysore Medical College and Research Institute, Mysore, Karnataka, India.
- Department of Biochemistry and Medical Genetics, JSS Medical College, Mysore, Karnataka, India.
- Department of Geriatric Medicine, JSS Hospital, Mysore, Karnataka, India.
- Department of Anatomy, AIMST University, Bedong, Kedah, Malaysia.
ORCID-Profile: Ram Prakash Sah
Zitieren
APA
Sah, R. P., Cs, V., Jayaram, S., Yadav, A. K., Pereira, P., & Damodaran, J. (2026). Impact of Vitamin B12, Folate and Homocysteine in Modulating Cognitive Functions and the Brain’s White Matter Hyperintensity in Alzheimer’s Disease. Annals of Neurosciences. https://doi.org/10.1177/09727531261457693
Vancouver
Sah RP, Cs V, Jayaram S, Yadav AK, Pereira P, Damodaran J. Impact of Vitamin B12, Folate and Homocysteine in Modulating Cognitive Functions and the Brain’s White Matter Hyperintensity in Alzheimer’s Disease. Annals of Neurosciences. 2026. doi:10.1177/09727531261457693
BibTeX
@article{Sah2026,
author = {Sah, Ram Prakash and Cs, Vidya and Jayaram, Shubha and Yadav, Anshu Kumar and Pereira, Pratibha and Damodaran, Jagdeesh},
title = {Impact of Vitamin B12, Folate and Homocysteine in Modulating Cognitive Functions and the Brain’s White Matter Hyperintensity in Alzheimer’s Disease},
journal = {Annals of Neurosciences},
year = {2026},
doi = {10.1177/09727531261457693}
}
EUVIMED